Looks like FASN plays a critical role in NLRP3 inflammasome activation. 
NLRP3 inhibitors are currently explored for obesity and Alzheimer's, e g. $vtyx. So, FASN inhibitors can also play a role here. One more angle to consider for $sgmt valuation 

https://t.co/HSQcCA3N6Z